Georg Roth

Georg currently serves as Chief Technology Officer and is responsible for technical operations at CG Oncology. He has over 30 years of experience in the biopharmaceutical industry, developing biological processes and directing manufacturing operations. Until 2019, Georg was COO and SVP Technical Operations at Sillajen Biotherapeutics where he oversaw U.S. operations and headed all technical functions for the development of oncolytic viruses. Prior to Sillajen Biotherapeutics, Georg was VP Technical Operations at Jennerex. Earlier in his career, he held roles of increasing responsibility at Dynavax Technologies, Berlex Biosciences and Schering AG.​